Annual Operating Profit:
-$3.94B+$294.00M(+6.94%)Summary
- As of today, MRNA annual operating income is -$3.94 billion, with the most recent change of +$294.00 million (+6.94%) on December 31, 2024.
- During the last 3 years, MRNA annual operating profit has fallen by -$17.24 billion (-129.67%).
- MRNA annual operating profit is now -129.67% below its all-time high of $13.30 billion, reached on December 31, 2021.
Performance
MRNA Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Profit:
-$907.00M+$143.00M(+13.62%)Summary
- As of today, MRNA quarterly operating income is -$907.00 million, with the most recent change of +$143.00 million (+13.62%) on June 30, 2025.
- Over the past year, MRNA quarterly operating profit has increased by +$456.00 million (+33.46%).
- MRNA quarterly operating profit is now -116.77% below its all-time high of $5.41 billion, reached on December 31, 2021.
Performance
MRNA Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Operating Profit:
-$3.27B+$456.00M(+12.23%)Summary
- As of today, MRNA TTM operating income is -$3.27 billion, with the most recent change of +$456.00 million (+12.23%) on June 30, 2025.
- Over the past year, MRNA TTM operating profit has increased by +$1.36 billion (+29.39%).
- MRNA TTM operating profit is now -120.13% below its all-time high of $16.26 billion, reached on March 31, 2022.
Performance
MRNA TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
MRNA Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +6.9% | +33.5% | +29.4% |
| 3Y3 Years | -129.7% | -137.1% | -120.9% |
| 5Y5 Years | -622.5% | -643.4% | -429.7% |
MRNA Operating Profit Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -129.7% | +6.9% | -157.4% | +54.9% | -124.7% | +36.3% |
| 5Y | 5-Year | -129.7% | +6.9% | -116.8% | +54.9% | -120.1% | +36.3% |
| All-Time | All-Time | -129.7% | +6.9% | -116.8% | +54.9% | -120.1% | +36.3% |
MRNA Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$907.00M(+13.6%) | -$3.27B(+12.2%) |
| Mar 2025 | - | -$1.05B(+15.7%) | -$3.73B(+5.5%) |
| Dec 2024 | -$3.94B(+6.9%) | -$1.25B(-1680.0%) | -$3.94B(-46.5%) |
| Sep 2024 | - | -$70.00M(+94.9%) | -$2.69B(+41.9%) |
| Jun 2024 | - | -$1.36B(-7.7%) | -$4.63B(+9.8%) |
| Mar 2024 | - | -$1.27B(>-9900.0%) | -$5.14B(-21.2%) |
| Dec 2023 | -$4.24B(-145.0%) | $6.00M(+100.3%) | -$4.24B(-59.1%) |
| Sep 2023 | - | -$2.01B(-7.8%) | -$2.67B(-619.5%) |
| Jun 2023 | - | -$1.87B(-410.1%) | $513.00M(-89.4%) |
| Mar 2023 | - | -$366.00M(-123.2%) | $4.83B(-48.8%) |
| Dec 2022 | $9.42B(-29.2%) | $1.58B(+35.5%) | $9.42B(-28.9%) |
| Sep 2022 | - | $1.17B(-52.3%) | $13.25B(-15.3%) |
| Jun 2022 | - | $2.45B(-42.1%) | $15.64B(-3.8%) |
| Mar 2022 | - | $4.23B(-21.9%) | $16.26B(+22.3%) |
| Dec 2021 | $13.30B(+1842.6%) | $5.41B(+52.1%) | $13.30B(+74.7%) |
| Sep 2021 | - | $3.56B(+16.2%) | $7.61B(+99.3%) |
| Jun 2021 | - | $3.06B(+141.9%) | $3.82B(+502.2%) |
| Mar 2021 | - | $1.27B(+560.4%) | $634.00M(+183.1%) |
| Dec 2020 | -$763.00M(-39.7%) | -$275.00M(-17.0%) | -$763.00M(-23.5%) |
| Sep 2020 | - | -$235.00M(-92.6%) | -$617.89M(-20.3%) |
| Jun 2020 | - | -$122.00M(+6.9%) | -$513.65M(+4.1%) |
| Mar 2020 | - | -$131.00M(-0.9%) | -$535.36M(+1.9%) |
| Dec 2019 | -$546.00M(-32.1%) | -$129.89M(+0.7%) | -$546.00M(+4.1%) |
| Sep 2019 | - | -$130.76M(+9.0%) | -$569.14M(-8.6%) |
| Jun 2019 | - | -$143.71M(-1.5%) | -$524.20M(-9.8%) |
| Mar 2019 | - | -$141.64M(+7.4%) | -$477.50M(-15.5%) |
| Dec 2018 | -$413.27M(-53.4%) | -$153.03M(-78.3%) | -$413.27M(-36.8%) |
| Sep 2018 | - | -$85.82M(+11.5%) | -$302.06M(-39.0%) |
| Jun 2018 | - | -$97.02M(-25.3%) | -$217.28M(-79.3%) |
| Mar 2018 | - | -$77.40M(-85.0%) | -$121.21M(-170.7%) |
| Dec 2017 | -$269.36M(-20.4%) | -$41.83M(-3937.5%) | -$44.78M(-1228.9%) |
| Sep 2017 | - | -$1.04M(-9.2%) | -$3.37M(-38.6%) |
| Jun 2017 | - | -$948.90K(+1.9%) | -$2.43M(-50.9%) |
| Mar 2017 | - | -$967.30K(-131.7%) | -$1.61M(-112.6%) |
| Dec 2016 | -$223.77M(-5509.7%) | - | - |
| Dec 2016 | - | -$417.40K(-327.2%) | -$757.70K(+21.1%) |
| Sep 2016 | - | -$97.70K(+23.9%) | -$960.30K(+49.3%) |
| Jun 2016 | - | -$128.40K(-12.4%) | -$1.89M(+32.0%) |
| Mar 2016 | - | -$114.20K(+81.6%) | -$2.79M(+30.1%) |
| Dec 2015 | -$3.99M(-13.3%) | -$620.00K(+39.9%) | -$3.99M(+1.5%) |
| Sep 2015 | - | -$1.03M(-1.0%) | -$4.05M(+12.4%) |
| Jun 2015 | - | -$1.02M(+22.3%) | -$4.62M(-8.2%) |
| Mar 2015 | - | -$1.31M(-93.7%) | -$4.27M(-21.4%) |
| Dec 2014 | -$3.52M(-864.4%) | -$679.00K(+57.7%) | -$3.52M(-24.9%) |
| Sep 2014 | - | -$1.61M(-139.5%) | -$2.82M(-159.2%) |
| Jun 2014 | - | -$671.00K(-19.2%) | -$1.09M(-80.6%) |
| Mar 2014 | - | -$563.00K(-2547.8%) | -$602.00K(-64.9%) |
| Dec 2013 | -$365.00K(+94.1%) | $23.00K(-81.5%) | -$365.00K(+78.2%) |
| Sep 2013 | - | $124.00K(+166.7%) | -$1.67M(+18.1%) |
| Jun 2013 | - | -$186.00K(+42.9%) | -$2.04M(+14.3%) |
| Mar 2013 | - | -$326.00K(+74.6%) | -$2.38M(+61.6%) |
| Dec 2012 | -$6.20M(+64.7%) | -$1.28M(-424.5%) | -$6.20M(+17.7%) |
| Sep 2012 | - | -$245.00K(+53.5%) | -$7.54M(+36.2%) |
| Jun 2012 | - | -$527.00K(+87.3%) | -$11.81M(+29.2%) |
| Mar 2012 | - | -$4.14M(-58.2%) | -$16.68M(+5.1%) |
| Dec 2011 | -$17.57M(+32.4%) | -$2.62M(+42.0%) | -$17.57M(+6.4%) |
| Sep 2011 | - | -$4.52M(+16.1%) | -$18.76M(+23.6%) |
| Jun 2011 | - | -$5.39M(-7.0%) | -$24.57M(+2.0%) |
| Mar 2011 | - | -$5.04M(-32.2%) | -$25.07M(+3.6%) |
| Dec 2010 | -$26.00M(-154.0%) | -$3.81M(+63.1%) | -$26.00M(+4.9%) |
| Sep 2010 | - | -$10.33M(-75.3%) | -$27.34M(-15.1%) |
| Jun 2010 | - | -$5.89M(+1.4%) | -$23.75M(+1.6%) |
| Mar 2010 | - | -$5.97M(-16.0%) | -$24.14M(-135.8%) |
| Dec 2009 | -$10.24M | -$5.15M(+23.5%) | -$10.24M(+40.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$6.73M(-7.2%) | -$17.14M(+15.1%) |
| Jun 2009 | - | -$6.28M(-179.2%) | -$20.18M(+28.3%) |
| Mar 2009 | - | $7.93M(+165.8%) | -$28.13M(+44.5%) |
| Dec 2008 | -$50.69M(+7.1%) | -$12.05M(-23.2%) | -$50.69M(+0.5%) |
| Sep 2008 | - | -$9.78M(+31.3%) | -$50.95M(+12.4%) |
| Jun 2008 | - | -$14.23M(+2.7%) | -$58.13M(-2.1%) |
| Mar 2008 | - | -$14.63M(-18.8%) | -$56.93M(-4.4%) |
| Dec 2007 | -$54.53M(-86.0%) | -$12.31M(+27.4%) | -$54.53M(-2.3%) |
| Sep 2007 | - | -$16.97M(-30.2%) | -$53.32M(-19.1%) |
| Jun 2007 | - | -$13.03M(-6.6%) | -$44.75M(-36.1%) |
| Mar 2007 | - | -$12.23M(-10.2%) | -$32.88M(-12.1%) |
| Dec 2006 | -$29.32M(+13.3%) | -$11.10M(-32.2%) | -$29.32M(-5.8%) |
| Sep 2006 | - | -$8.40M(-628.4%) | -$27.70M(+2.9%) |
| Jun 2006 | - | -$1.15M(+86.7%) | -$28.55M(+20.9%) |
| Mar 2006 | - | -$8.67M(+8.6%) | -$36.08M(-6.8%) |
| Dec 2005 | -$33.80M(-18.6%) | -$9.48M(-2.7%) | -$33.80M(-11.8%) |
| Sep 2005 | - | -$9.24M(-6.3%) | -$30.24M(-6.0%) |
| Jun 2005 | - | -$8.69M(-36.1%) | -$28.52M(-4.6%) |
| Mar 2005 | - | -$6.39M(-7.9%) | -$27.27M(+4.3%) |
| Dec 2004 | -$28.49M(-358.7%) | -$5.92M(+21.3%) | -$28.49M(+0.0%) |
| Sep 2004 | - | -$7.53M(-1.2%) | -$28.50M(-4.7%) |
| Jun 2004 | - | -$7.44M(+2.1%) | -$27.22M(-147.9%) |
| Mar 2004 | - | -$7.60M(-28.1%) | -$10.98M(-76.8%) |
| Dec 2003 | -$6.21M(+52.2%) | -$5.93M(+5.0%) | -$6.21M(-15.5%) |
| Sep 2003 | - | -$6.25M(-171.0%) | -$5.38M(-106.1%) |
| Jun 2003 | - | $8.80M(+410.7%) | -$2.61M(+79.9%) |
| Mar 2003 | - | -$2.83M(+44.5%) | -$12.96M(+0.2%) |
| Dec 2002 | -$12.99M(-36.0%) | -$5.10M(-46.6%) | -$12.99M(-18.3%) |
| Sep 2002 | - | -$3.48M(-124.1%) | -$10.98M(-16.9%) |
| Jun 2002 | - | -$1.55M(+45.8%) | -$9.40M(+6.1%) |
| Mar 2002 | - | -$2.86M(+7.4%) | -$10.01M(-4.8%) |
| Dec 2001 | -$9.55M(+7.6%) | -$3.09M(-63.2%) | -$9.55M(+5.9%) |
| Sep 2001 | - | -$1.89M(+12.4%) | -$10.15M(-0.5%) |
| Jun 2001 | - | -$2.16M(+10.0%) | -$10.11M(+2.5%) |
| Mar 2001 | - | -$2.40M(+35.0%) | -$10.36M(-0.3%) |
| Dec 2000 | -$10.34M(-9.3%) | -$3.69M(-99.9%) | -$10.34M(+2.4%) |
| Sep 2000 | - | -$1.85M(+23.5%) | -$10.59M(+1.1%) |
| Jun 2000 | - | -$2.42M(-1.8%) | -$10.71M(-7.2%) |
| Mar 2000 | - | -$2.38M(+39.9%) | -$9.99M(+0.2%) |
| Dec 1999 | -$9.45M(-301.9%) | -$3.95M(-101.5%) | -$10.02M(-17.6%) |
| Sep 1999 | - | -$1.96M(-15.4%) | -$8.51M(-24.3%) |
| Jun 1999 | - | -$1.70M(+29.2%) | -$6.85M(-28.0%) |
| Mar 1999 | - | -$2.40M(+2.1%) | -$5.35M(-69.8%) |
| Dec 1998 | -$2.35M(+60.8%) | -$2.45M(-717.3%) | -$3.15M(-1.7%) |
| Sep 1998 | - | -$300.00K(-50.0%) | -$3.10M(+31.1%) |
| Jun 1998 | - | -$200.00K(0.0%) | -$4.50M(+19.6%) |
| Mar 1998 | - | -$200.00K(+91.7%) | -$5.60M(+8.2%) |
| Dec 1997 | -$6.00M(-1100.0%) | -$2.40M(-41.2%) | -$6.10M(-64.9%) |
| Sep 1997 | - | -$1.70M(-30.8%) | -$3.70M(-85.0%) |
| Jun 1997 | - | -$1.30M(-85.7%) | -$2.00M(-300.0%) |
| Mar 1997 | - | -$700.00K(>-9900.0%) | -$500.00K(>-9900.0%) |
| Dec 1996 | -$500.00K(-400.0%) | - | - |
| Sep 1996 | - | $0.00(-100.0%) | $0.00(+100.0%) |
| Jun 1996 | -$100.00K(0.0%) | $200.00K(+100.0%) | -$100.00K(+66.7%) |
| Mar 1996 | - | $100.00K(+133.3%) | -$300.00K(+25.0%) |
| Dec 1995 | - | -$300.00K(-200.0%) | -$400.00K(-100.0%) |
| Sep 1995 | - | -$100.00K(>-9900.0%) | -$200.00K(>-9900.0%) |
| Jun 1995 | -$100.00K(-150.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 1995 | - | $0.00(+100.0%) | $100.00K(>+9900.0%) |
| Dec 1994 | - | -$100.00K(-200.0%) | $0.00(-100.0%) |
| Sep 1994 | - | $100.00K(0.0%) | $200.00K(0.0%) |
| Jun 1994 | $200.00K | $100.00K(+200.0%) | $200.00K(+100.0%) |
| Mar 1994 | - | -$100.00K(-200.0%) | $100.00K(-50.0%) |
| Dec 1993 | - | $100.00K(0.0%) | $200.00K(+100.0%) |
| Sep 1993 | - | $100.00K | $100.00K |
FAQ
- What is Moderna, Inc. annual operating income?
- What is the all-time high annual operating profit for Moderna, Inc.?
- What is Moderna, Inc. annual operating profit year-on-year change?
- What is Moderna, Inc. quarterly operating income?
- What is the all-time high quarterly operating profit for Moderna, Inc.?
- What is Moderna, Inc. quarterly operating profit year-on-year change?
- What is Moderna, Inc. TTM operating income?
- What is the all-time high TTM operating profit for Moderna, Inc.?
- What is Moderna, Inc. TTM operating profit year-on-year change?
What is Moderna, Inc. annual operating income?
The current annual operating profit of MRNA is -$3.94B
What is the all-time high annual operating profit for Moderna, Inc.?
Moderna, Inc. all-time high annual operating income is $13.30B
What is Moderna, Inc. annual operating profit year-on-year change?
Over the past year, MRNA annual operating income has changed by +$294.00M (+6.94%)
What is Moderna, Inc. quarterly operating income?
The current quarterly operating profit of MRNA is -$907.00M
What is the all-time high quarterly operating profit for Moderna, Inc.?
Moderna, Inc. all-time high quarterly operating income is $5.41B
What is Moderna, Inc. quarterly operating profit year-on-year change?
Over the past year, MRNA quarterly operating income has changed by +$456.00M (+33.46%)
What is Moderna, Inc. TTM operating income?
The current TTM operating profit of MRNA is -$3.27B
What is the all-time high TTM operating profit for Moderna, Inc.?
Moderna, Inc. all-time high TTM operating income is $16.26B
What is Moderna, Inc. TTM operating profit year-on-year change?
Over the past year, MRNA TTM operating income has changed by +$1.36B (+29.39%)